Wheatland Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$705K Sell
4,293
-200
-4% -$30.7K 2.92% 12
2020
Q1
$623K Sell
4,493
-5,199
-54% -$714K 3.17% 12
2019
Q4
$1.27M Sell
9,692
-7,349
-43% -$852K 1.62% 18
2019
Q3
$1.91M Sell
17,041
-11,800
-41% -$1.31M 1.73% 15
2019
Q2
$3.19M Sell
28,841
-374
-1% -$44K 2.41% 10
2019
Q1
$3.79M Hold
29,215
2.89% 6
2018
Q4
$3.38M Buy
29,215
+2
+0% +$223 2.95% 6
2018
Q3
$3.13M Sell
29,213
-23
-0.1% -$2.3K 2.36% 13
2018
Q2
$2.5M Buy
29,236
+2
+0% +$164 2.02% 14
2018
Q1
$2.26M Buy
29,234
+2
+0% +$161 1.87% 17
2017
Q4
$2.47M Buy
29,232
+2
+0% +$170 2% 15
2017
Q3
$2.5M Buy
29,230
+2
+0% +$164 2.14% 14
2017
Q2
$2.4M Sell
29,228
-1,397
-5% -$114K 2.17% 14
2017
Q1
$2.58M Sell
30,625
-998
-3% -$79.9K 2.3% 12
2016
Q4
$2.33M Sell
31,623
-148
-0.5% -$11K 2.06% 15
2016
Q3
$2.55M Buy
31,771
+2
+0% +$160 2.4% 11
2016
Q2
$2.5M Sell
31,769
-398
-1% -$30K 2.4% 11
2016
Q1
$2.32M Buy
32,167
+2
+0% +$151 2.37% 12
2015
Q4
$2.71M Buy
32,165
+2
+0% +$166 2.77% 6
2015
Q3
$2.69M Buy
32,163
+2
+0% +$169 2.92% 5
2015
Q2
$2.69M Sell
32,161
-198
-0.6% -$15.1K 2.58% 9
2015
Q1
$2.35M Sell
32,359
-98
-0.3% -$6.98K 2.34% 14
2014
Q4
$2.24M Sell
32,457
-548
-2% -$37K 2.18% 15
2014
Q3
$2.14M Sell
33,005
-347
-1% -$22K 2.14% 16
2014
Q2
$1.13M Sell
33,352
-398
-1% -$23.7K 1.03% 41
2014
Q1
$1.99M Buy
33,750
+200
+0.6% +$11.2K 2.03% 17
2013
Q4
$1.71M Buy
+33,550
New +$1.68M 1.79% 23

Other funds holding LLY

Wheatland Advisors's LLY Position: Q2 2020 in Review

Wheatland Advisors reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2020, selling an estimated $30.7K and leaving 4,293 shares worth $705K. The position accounts for 2.92% of the portfolio, ranked #12.

Wheatland Advisors first reported a position in LLY in Q4 2013 and has held it in 27 quarters since. The position peaked at $3.79M in Q1 2019. 1,764 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Wheatland Advisors held 4,293 shares of Eli Lilly worth $705K as of Q2 2020.
  • Wheatland Advisors sold 200 Eli Lilly shares in Q2 2020, an estimated $30.7K.
  • Eli Lilly made up 2.92% of Wheatland Advisors's portfolio in Q2 2020, its #12 holding.
  • Wheatland Advisors first reported a position in Eli Lilly in Q4 2013 and has held it in 27 quarters since.
  • Wheatland Advisors's Eli Lilly position peaked at $3.79M in Q1 2019.
  • 1,764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Wheatland Advisors's 13F filing for Q2 2020, filed 28 Jul 2020.